FREXERA
Live / Allowed — Notice of allowance issued (as of 05 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99397783
- Mark type
- Design + words
- Filed
- 17 Sept 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 10 Sept 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Feb 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Oct 2025 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 01 Oct 2025 — ASSIGNED TO LIE
- 25 Sept 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 17 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Sept 2025 — NEW APPLICATION ENTERED